IRIS
COLOMBO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 676
NA - Nord America 627
AS - Asia 75
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 1
Totale 1.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 618
SE - Svezia 515
IT - Italia 71
CN - Cina 26
IE - Irlanda 23
FI - Finlandia 21
DE - Germania 16
GB - Regno Unito 15
IR - Iran 10
JP - Giappone 9
SG - Singapore 7
CA - Canada 6
HK - Hong Kong 6
IN - India 6
EU - Europa 4
FR - Francia 4
PK - Pakistan 4
MX - Messico 3
NL - Olanda 3
DK - Danimarca 2
ES - Italia 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TH - Thailandia 2
AT - Austria 1
CZ - Repubblica Ceca 1
PH - Filippine 1
TR - Turchia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 1.383
Salva come PNG Salva come JPEG
Città #
Lawrence 191
Princeton 191
Ashburn 47
New York 35
Milan 28
Shanghai 25
Dublin 22
Helsinki 19
Durham 6
Rome 5
Genoa 4
Islington 4
Khanewal 4
Kobe 4
Springfield 4
Bari 3
Edinburgh 3
Los Angeles 3
Monterrey 3
Naaldwijk 3
Seattle 3
Bethesda 2
Borås 2
Central 2
Copenhagen 2
Delhi 2
Gourock 2
Hamburg 2
Hong Kong 2
Jeddah 2
Lappeenranta 2
Madrid 2
Monza 2
Moscow 2
Mountain View 2
Phuket 2
Pistoia 2
Pune 2
Redwood City 2
Romainville 2
Sesto San Giovanni 2
Tokyo 2
Torre del Lago Puccini 2
Toshima 2
Vadodara 2
Vancouver 2
Washington 2
Arezzo 1
Beijing 1
Bulgorello 1
Castiglione D'adda 1
Cheyenne 1
Chivasso 1
Cork 1
Dalsjoefors 1
Earls Court 1
Gouesnou 1
Hanover 1
Istanbul 1
Kashan 1
Kish 1
Leawood 1
Makati City 1
Modena 1
Montechiarugolo 1
Montevideo 1
Montreal 1
Napoli 1
Redondo Beach 1
Rende 1
Riverside 1
Taipei 1
Tehran 1
Toyonaka 1
Vienna 1
Totale 687
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 22
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 22
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 22
Diabetes and mortality in patients with COVID-19: Are we missing the link? 20
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 19
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 19
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 19
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 19
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 18
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 18
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 18
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 16
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 16
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 16
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 16
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 16
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 15
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 15
[New therapeutic options for the treatment of tricuspid regurgitation] 15
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 14
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 14
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 14
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 14
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 14
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 14
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 13
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 13
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 13
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 13
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 13
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 12
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 12
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 12
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve replacement: incidence, time course and predictive factors 12
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 11
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 11
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 11
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 11
[40 Years of coronary angioplasty: success comes from skills and determination!] 11
Clinical and anatomical predictors of mitraclip therapy failure for functional mitral regurgitation. 11
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 11
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 11
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 11
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 11
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 11
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 10
Outcomes in coronary stents trials - 1 year is not enough 10
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 10
Left atrial appendage closure: A single center experience and comparison of two contemporary devices 10
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 10
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 10
Advances in percutaneous interventional therapies: The tricuspid valve 10
FEVER AFTER TAVI (TRANSCATHETER AORTIC VALVE IMPLANTATION): IS IT INFLAMMATION OR INFECTION? 10
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media 10
Coronary Access After Repeated Transcatheter Aortic Valve Implantation: A Glimpse Into the Future 10
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 10
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 10
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 9
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 9
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 9
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 9
Contrast-induced kidney injury: how does it affect long-term cardiac mortality? 9
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 9
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 9
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 9
Radiation exposure and contrast agent reduction during transcatheter aortic valve implantation: An ongoing experience 9
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 9
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 9
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 9
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 9
Relationship between Syntax Score and prognostic localization of coronary artery lesions with conventional risk factors, plasma profile markers, and carotid atherosclerosis (CAPP Study 2) 9
A new tool for the forgotten valve: a score to predict the risk of surgery 8
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 8
Rotational atherectomy in the subadventitial space to allow safe and successful chronic total occlusion recanalization: Pushing the limit further 8
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 8
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 8
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 8
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study 8
Percutaneous treatment of an iatrogenic aorta-to-right atrium fistula 8
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 8
Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis 8
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 7
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 7
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 7
Echocardiographic 'brainstorm' to detect anomalous origin of the left coronary artery from the pulmonary artery 7
Percutaneous Transcatheter Treatment for Tricuspid Bioprosthesis Failure 7
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 7
Use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures 7
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 7
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 7
Transfemoral Implantation of a Balloon-Expandable Transcatheter Valve in a Rigid Mitral Annuloplasty Ring Optimized by Post-Dilatation 7
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 7
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 7
Trans-subclavian versus transapical access for transcatheter aortic valve implantation: A multicenter study 7
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 7
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 7
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 7
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 7
Optimal implantation is the way to prevent scaffold thrombosis: a hypothesis to be tested 7
Subintimal Crush of an Occluded Stent to Recanalize a Chronic Total Occlusion Due to In-Stent Restenosis: Insights From a Multimodality Imaging Approach 7
Totale 1.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.673
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.673
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 3 0 0 5 2 0 0 0 0 0 0 0
2020/202128 0 0 1 8 1 13 0 0 2 1 1 1
2021/202299 5 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024320 19 32 53 59 37 50 13 41 5 10 1 0
Totale 1.644